Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.7.0.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenues:    
Revenue from services $ 255,286 $ 252,522
Revenue from products 22,231 19,899
Revenue from transfer of intellectual property and other 18,579 18,616
Total revenues 296,096 291,037
Costs and expenses:    
Cost of service revenue 139,966 137,597
Cost of product revenue 14,830 9,939
Selling, general and administrative 136,685 128,001
Research and development 26,022 27,822
Contingent consideration 2,371 1,753
Amortization of intangible assets 17,929 13,443
Total costs and expenses 337,803 318,555
Operating loss (41,707) (27,518)
Other income and (expense), net:    
Interest income 249 43
Interest expense (1,429) (1,787)
Fair value changes of derivative instruments, net 4,037 (1,423)
Other income (expense), net 3,042 546
Other income and (expense), net 5,899 (2,621)
Loss before income taxes and investment losses (35,808) (30,139)
Income tax benefit 6,944 20,506
Net loss before investment losses (28,864) (9,633)
Loss from investments in investees (2,131) (2,345)
Net loss $ (30,995) $ (11,978)
Loss per share, basic and diluted:    
Net loss per share, basic and diluted (in dollars per share) $ (0.06) $ (0.02)
Weighted average common shares outstanding, basic and diluted (in shares) 558,434,153 545,823,434